Tango Therapeutics, Inc. (TNGX)
Market Open
26 Oct, 06:12 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
22. 51
-0.83
-3.5561%
$
3.72B Market Cap
- P/E Ratio
- Div Yield
195,375 Volume
-1.29 Eps
$ 23.34
Previous Close 
Want to track TNGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
TNGX Earnings Reports FAQ
What is the earnings per share (EPS) for TNGX?
The current EPS is -1.29.
What is the company's earnings growth rate?
Tango Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Tango Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Tango Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TNGX at this time, as Tango Therapeutics, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
